⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13086754 | 0.70 | — | — | |
| SCHEMBL13086592 | 0.69 | — | — | |
| SCHEMBL13086590 | 0.66 | — | — | |
| SCHEMBL24803729 | 0.64 | HTR2C (0.45) | — | |
| SCHEMBL13086599 | 0.62 | — | — | |
| SCHEMBL24803725 | 0.62 | HTR2C (0.43) | — | |
| SCHEMBL25060986 | 0.60 | HTR2C (0.42) | — | |
| SCHEMBL20609562 | 0.57 | HTR2C (0.52) | — | |
| SCHEMBL18237939 | 0.57 | MAOA (0.32) | — | |
| SCHEMBL5951002 | 0.57 | CHRNA7 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100261679-A1 | CSF-1R, Inhibitors, Compositions, and Methods of Use | NOVARTIS AG (CH) | 2010-10-14 | — | — | US | disclosed |